Decentralized clinical trials in 2021 — with John Reites

The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field — now generally referred to as "decentralized clinical trials" — has been advancing and gaining traction ever since. But, like so many other remote tools, it's been greatly accelerated by the COVID-19 pandemic.On today's HIMSSCast, host Jonah Comstock and MobiHealthNews Managing Editor Laura Lovett welcome John Reites, CEO and cofounder of THREAD Research, to give us an update on where this new paradigm for clinical trials is today, and where it's headed.Talking points:The effect of the pandemic on decentralized clinical trialsReconciling cultural differences between pharma and techHow vaccine trials are their own animalHow decentralized trials can help improve clinical trial diversityThe role of consumer wearables in clinical trials todayWhy clinical trial innovation must be globalHow physicians, researchers, and patients are responding to new clinical trial modelsWhat everyone should know about decentralized clinical trialsMore about this episode:THREAD ResearchThat Apple videoTrials and tribulations – the new world of decentralized trialsSpurred by the pandemic, AI is driving decentralized clinical trialsVirtual clinical research company Thread acquired by two private equity firmsExo raises $40M for handheld ultrasound; decentralized trial platforms raise nearly $100M; and more digital health funding newsCurrent Health launches decentralized clinical trial initiativeDecentralized clinical trial startup Florence lands $80M for company growthLabcorp updates its clinical trial process with a technology-enabled platformThe year for mobile-enabled clinical trials: 2013 or 2030? (Throwback #1)ResearchKit update: Notes from the field on trial retention, Android integration, and more (Throwback #2)